LYKA LABS
Smallcap | BSE
Sector
Here's the live share price of Lyka Labs along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-0.75₹ -0.50
As on Aug 14, 2026, 04:01 PM IST
Source: Dion Global
Lyka Labs Price Performance
Today's LowToday's High
₹66.55₹67.01
₹66.55
52 Weeks' Low52 Weeks' High
₹44.49₹109.85
₹66.55
Open Price
₹67.01
Prev. Close
₹67.05
Volume
2,150
Source: Dion Global
Lyka Labs Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Lyka Labs | -1.58 | -4.93 | 6.67 | -2.13 | -33.35 | -16.17 | -4.49 |
| Sun Pharmaceutical Industries | -1.24 | -0.79 | 3.31 | 13.25 | 17.19 | 19.26 | 19.78 |
| Divi's Laboratories | 3.05 | 18.30 | 22.80 | 38.13 | 38.66 | 31.58 | 11.64 |
| Torrent Pharmaceuticals | -2.26 | -2.63 | 9.78 | 13.61 | 33.63 | 34.92 | 26.78 |
| Cipla | -1.49 | 0.80 | 0.79 | 6.95 | -7.27 | 5.49 | 10.29 |
| Zydus Lifesciences | 2.22 | 0.54 | 15.00 | 25.27 | 15.29 | 21.13 | 16.47 |
| Lupin | -5.30 | -9.49 | -1.01 | 0.65 | 14.04 | 27.37 | 18.23 |
| Dr. Reddy's Laboratories | 2.56 | -3.51 | -7.74 | -5.30 | -4.55 | 1.08 | 5.21 |
| Mankind Pharma | -0.78 | -4.37 | -1.70 | 16.23 | -2.12 | 10.00 | 11.19 |
| Laurus Labs | -2.16 | 16.35 | 37.96 | 79.20 | 111.20 | 67.73 | 21.37 |
| Aurobindo Pharma | -0.18 | 6.77 | 9.83 | 39.93 | 53.11 | 23.90 | 17.57 |
| Biocon | -3.51 | -5.12 | -1.01 | 9.11 | 15.46 | 17.69 | 2.48 |
| Glenmark Pharmaceuticals | 2.32 | 1.50 | -0.01 | 15.19 | 14.48 | 43.16 | 32.67 |
| Alkem Laboratories | -4.11 | -3.56 | -3.23 | -1.48 | 1.00 | 12.50 | 7.76 |
| Abbott India | -2.52 | -1.60 | -1.58 | 2.88 | -18.52 | 4.68 | 7.40 |
| Anthem Biosciences | 5.73 | 18.52 | 8.62 | 29.14 | 7.64 | 6.77 | 4.01 |
| Gland Pharma | 14.32 | 19.53 | 56.86 | 64.31 | 50.59 | 22.87 | -6.37 |
| Ajanta Pharma | 5.65 | 7.93 | 12.96 | 25.24 | 37.36 | 28.71 | 19.40 |
| GlaxoSmithKline Pharmaceuticals | 3.72 | 9.18 | 11.24 | 3.51 | -2.85 | 23.85 | 10.85 |
| Ipca Laboratories | -0.51 | -6.09 | 9.18 | 15.20 | 26.33 | 25.04 | 7.45 |
Source: Dion Global
Over the last one year, Lyka Labs has declined 33.35% compared to peers like Sun Pharmaceutical Industries (17.19%), Divi's Laboratories (38.66%), Torrent Pharmaceuticals (33.63%). From a 5 year perspective, Lyka Labs has underperformed peers relative to Sun Pharmaceutical Industries (19.78%) and Divi's Laboratories (11.64%).
Lyka Labs Financials
Source: Dion Global
Lyka Labs Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 68.1 | 67.44 |
| 10 | 65.8 | 66.71 |
| 20 | 65.49 | 66.52 |
| 50 | 67.89 | 66.32 |
| 100 | 62.76 | 66.61 |
| 200 | 69.86 | 72.94 |
Source: Dion Global
Lyka Labs Share Holding Pattern
In the latest quarter, Lyka Labs saw a rise in promoter holding to 58.46%, while DII stake unchanged at 0.66%, FII holding fell to 0.17%, and public shareholding moved down to 40.73% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Lyka Labs Corporate Actions
Date Time | Announcement |
|---|---|
| Aug 11, 2026, 11:13 PM IST IST | Lyka Labs - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report |
| Aug 11, 2026, 08:37 PM IST IST | Lyka Labs - Revised Press Release On Unaudited Financial Results For The Q1 June, 2026 |
| Aug 10, 2026, 09:17 PM IST IST | Lyka Labs - Shareholder Meeting / Postal Ballot-Outcome of AGM |
| Aug 10, 2026, 06:17 AM IST IST | Lyka Labs - Press Release For Unaudited Financial Results Of Q1 June 2026 |
| Aug 10, 2026, 05:58 AM IST IST | Lyka Labs - Financial Results For June 2026 |
Source: Dion Global
About Lyka Labs
Lyka Labs Ltd. is a Public Limited Listed company incorporated on 29/12/1976 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24230GJ1976PLC008738 and registration number is 008738. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 120.91 Cr. and Equity Capital is Rs. 35.69 Cr. for the Year ended 31/03/2026.
- IndustryPharmaceuticals
- Address4801/B & 4802/A, Ankleshwar Gujarat 393002
- Contact
Source: Dion Global
Management
- Mr. Babulal JainChairman
- Mr. Kunal GandhiManaging Director & CEO
- Mr. Yogesh ShahWhole Time Director
- Mr. Shashil MendosaNon Executive Director
- Mr. Prashant GodhaNon Executive Director
- Mr. Neeraj GolasIndependent Director
- Ms. Archana S YadavIndependent Director
FAQs on Lyka Labs Share Price
What is the share price of Lyka Labs?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Lyka Labs is ₹66.55 as on Aug 14, 2026.
What kind of stock is Lyka Labs?
The Lyka Labs is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Lyka Labs?
The market cap of Lyka Labs is ₹237.52 Cr as on Aug 14, 2026.
What are today's High and Low prices of Lyka Labs?
Today’s highest and lowest price of Lyka Labs are ₹67.01 and ₹66.55.
What are the 52 Week High and 52 Week Low of Lyka Labs?
The 52-week high/low is the highest and lowest price at which Lyka Labs stock has traded in the past 52-week or nearly a year. The 52-week high of Lyka Labs is ₹109.85 and 52-week low of Lyka Labs is ₹44.49 as on Aug 14, 2026.
How has the Lyka Labs performed historically in terms of returns?
The Lyka Labs has shown returns of -0.75% over the past day, -4.93% for the past month, 6.67% over 3 months, -33.35% over 1 year, -16.17% across 3 years, and -4.49% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Lyka Labs?
P/E ratio of and PB ratio of Lyka Labs are -26.69 and 2.57 on Aug 14, 2026. While the company gives a dividend yield of 0.00 per annum.
Source: Dion Global
✕